Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bagdy

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Biological Psychiatry|March 15, 1989
Prolactin response to fentanyl in depressionE Frecska, M Arato, C M Banki, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 1988
Diurnal variation in fentanyl-induced hormone responses and side effectsE Frecska, M Arato, C M Banki, et al.
Endocrinology|April 1, 1990
Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the ratA E Calogero, G Bagdy, K Szemeredi, et al.
Neuropathology and Applied Neurobiology|March 16, 2007
Single dose of MDMA causes extensive decrement of serotoninergic fibre density without blockage of the fast axonal transport in Dark Agouti rat brain and spinal cordG G Kovács, R D Andó, C Adori, et al.
Journal of Neurochemistry|June 1, 1992
Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in ratsR Kvetnanský, D S Goldstein, V K Weise, et al.
Translational Psychiatry|May 4, 2016
Financial difficulties but not other types of recent negative life events show strong interactions with 5-HTTLPR genotype in the development of depressive symptomsX Gonda, N Eszlari, D Kovacs, et al.
Brain Research|December 24, 1990
Beta-endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary actionG Bagdy, A E Calogero, K Szemeredi, et al.
Journal of Neural Transmission|January 1, 1988
Effect of adjuvant reserpine treatment on catecholamine metabolism in schizophrenic patients under long-term neuroleptic treatmentG Bagdy, A Perenyi, E Frecska, et al.
Journal of Affective Disorders|May 6, 2008
Towards a genetically validated new affective temperament scale: a delineation of the temperament phenotype of 5-HTTLPR using the TEMPS-AX Gonda, K N Fountoulakis, Z Rihmer, et al.
Endocrinology|April 1, 1994
Male Fischer 344/N rats show a progressive central impairment of the hypothalamic-pituitary-adrenal axis with advancing ageG Cizza, A E Calogero, L S Brady, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Biological Psychiatry|March 15, 1989
Prolactin response to fentanyl in depressionE Frecska, M Arato, C M Banki, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 1988
Diurnal variation in fentanyl-induced hormone responses and side effectsE Frecska, M Arato, C M Banki, et al.
Endocrinology|April 1, 1990
Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the ratA E Calogero, G Bagdy, K Szemeredi, et al.
Neuropathology and Applied Neurobiology|March 16, 2007
Single dose of MDMA causes extensive decrement of serotoninergic fibre density without blockage of the fast axonal transport in Dark Agouti rat brain and spinal cordG G Kovács, R D Andó, C Adori, et al.
Journal of Neurochemistry|June 1, 1992
Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in ratsR Kvetnanský, D S Goldstein, V K Weise, et al.
Translational Psychiatry|May 4, 2016
Financial difficulties but not other types of recent negative life events show strong interactions with 5-HTTLPR genotype in the development of depressive symptomsX Gonda, N Eszlari, D Kovacs, et al.
Brain Research|December 24, 1990
Beta-endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary actionG Bagdy, A E Calogero, K Szemeredi, et al.
Journal of Neural Transmission|January 1, 1988
Effect of adjuvant reserpine treatment on catecholamine metabolism in schizophrenic patients under long-term neuroleptic treatmentG Bagdy, A Perenyi, E Frecska, et al.
Journal of Affective Disorders|May 6, 2008
Towards a genetically validated new affective temperament scale: a delineation of the temperament phenotype of 5-HTTLPR using the TEMPS-AX Gonda, K N Fountoulakis, Z Rihmer, et al.
Endocrinology|April 1, 1994
Male Fischer 344/N rats show a progressive central impairment of the hypothalamic-pituitary-adrenal axis with advancing ageG Cizza, A E Calogero, L S Brady, et al.
Pageof 8